Clinical Trial Update: Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating individualized radiation dose escalation in Stage III non-small cell lung cancer using modern chemoradiotherapy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Radboud University Medical Center | Conditions: Stage III Non-small Cell Lung Cancer, Individualized Radiation Dose Escalation | Phase 2 | Status: TERMINATED